Atlas Trials

Description of Real World Antiviral Effectiveness and Sustainability of the 2-Drug Regimen Dolutegravir + Lamivudine in Untreated and Pre-treated Patients in Routine Clinical Care in Germany

Clinical trial NCT03754803 · COMPLETED

Trial details

NCT number
NCT03754803
Sponsor
ViiV Healthcare
Status
COMPLETED
Study type
OBSERVATIONAL
HIV Infections
Start date
2018-11-08
Primary completion
2024-05-06
Enrollment
376

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.